Effects of early-onset colorectal cancer on reproductive health
Physiological and psychosocial aspects of reproductive health after early-onset colorectal cancer
This study is looking at how early-onset colorectal cancer and its treatments impact the reproductive health of adults aged 18 to 49, so we can better understand their fertility and sexual health concerns over time.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11075793 on NIH RePORTER |
What this research studies
This research investigates how early-onset colorectal cancer (CRC) and its treatments affect the reproductive health of adults aged 18 to 49. It aims to gather prospective data on fertility and sexual health concerns faced by CRC survivors, using validated questionnaires and qualitative interviews to assess changes over time. By focusing on both physiological and psychosocial aspects, the study seeks to identify the specific reproductive health needs of this patient population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 18 to 49 who have been diagnosed with early-onset colorectal cancer.
Not a fit: Patients outside the age range of 18 to 49 or those who have not been diagnosed with early-onset colorectal cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved reproductive health care and support for young adults affected by colorectal cancer.
How similar studies have performed: While there is limited research specifically addressing reproductive health in early-onset CRC survivors, similar studies in cancer survivorship have shown promising results in understanding and addressing psychosocial health needs.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Holowatyj, Andreana Natalie — Vanderbilt University Medical Center
- Study coordinator: Holowatyj, Andreana Natalie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.